GALLO, ANGELA
GALLO, ANGELA
Dipartimento di Scienze Umane e Promozione della Qualità della Vita
A Novel Computational Strategy to Identify A-to-I RNA Editing Sites by RNA-Seq Data: De Novo Detection in Human Spinal Cord Tissue
2012-01-01 Picardi, E.; Gallo, A.; Galeano, F.; Tomaselli, S.; Pesole, G.
A-to-I RNA editing and cancer: From pathology to basic science
2008-01-01 Gallo, A.; Galardi, S.
A-to-I RNA editing: The "ADAR" side of human cancer
2012-01-01 Galeano, F.; Tomaselli, S.; Locatelli, F.; Gallo, A.
ADAR enzyme and miRNA story: A nucleotide that can make the difference
2013-01-01 Tomaselli, S.; Bonamassa, B.; Alisi, A.; Nobili, V.; Locatelli, F.; Gallo, A.
ADAR RNA editing in human disease; more to it than meets the I
2017-01-01 Gallo, A.; Vukic, D.; Michalik, D.; O'Connell, M. A.; Keegan, L. P.
ADAR-mediated RNA editing of DNA:RNA hybrids is required for DNA double strand break repair
2021-01-01 Jimeno, S.; Prados-Carvajal, R.; Fernandez-Avila, M. J.; Silva, S.; Silvestris, D. A.; Endara-Coll, M.; Rodriguez-Real, G.; Domingo-Prim, J.; Mejias-Navarro, F.; Romero-Franco, A.; Jimeno-Gonzalez, S.; Barroso, S.; Cesarini, V.; Aguilera, A.; Gallo, A.; Visa, N.; Huertas, P.
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism
2021-01-01 Tassinari, V.; Cesarini, V.; Tomaselli, S.; Ianniello, Z.; Silvestris, D. A.; Ginistrelli, L. C.; Martini, M.; De Angelis, B.; De Luca, G.; Vitiani, L. R.; Fatica, A.; Locatelli, F.; Gallo, A.
ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas
2013-01-01 Tomaselli, S.; Galeano, F.; Massimi, L.; Di Rocco, C.; Lauriola, L.; Mastronuzzi, A.; Locatelli, F.; Gallo, A.
ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor
2011-01-01 Doria, M.; Tomaselli, S.; Neri, F.; Ciafre, S. A.; Farace, M. G.; Michienzi, A.; Gallo, A.
ADAR2 induces the differentiation of osteosarcoma cells by editing activity on IGFBP7: new implications for therapy
2026-01-01 Rossi, M.; Scotto Di Carlo, F.; Di Gregorio, J.; Russo, S.; Di Giuseppe, L.; Battafarano, G.; Terreri, S.; Pagliarosi, O.; Silvestris, D. A.; Corona, M.; Barra, A.; Pezzullo, M.; De Stefanis, C.; Pelle, S.; Costici, P. F.; Minisola, S.; Pepe, J.; Locatelli, F.; Gianfrancesco, F.; Gallo, A.; Del Fattore, A.
ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature
2022-01-01 Cesarini, V.; Silvestris, D. A.; Galeano, F.; Tassinari, V.; Martini, M.; Locatelli, F.; Gallo, A.
ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis
2013-01-01 Galeano, F.; Rossetti, C.; Tomaselli, S.; Cifaldi, L.; Lezzerini, M.; Pezzullo, M.; Boldrini, R.; Massimi, L.; Di Rocco, C. M.; Locatelli, F.; Gallo, A.
ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion
2018-01-01 Cesarini, V.; Silvestris, D. A.; Tassinari, V.; Tomaselli, S.; Alon, S.; Eisenberg, E.; Locatelli, F.; Gallo, A.
Adars and the balance game between virus infection and innate immune cell response
2015-01-01 Tomaselli, S.; Galeano, F.; Locatelli, F.; Gallo, A.
ADARs: Allies or enemies? The importance of A-to-I RNA editing in human disease: From cancer to HIV-1
2012-01-01 Gallo, A.; Locatelli, F.
AKT-Dependent Phosphorylation of ADAR1p110 and ADAR2 Represents a New and Important Link between Cell Signaling and RNA Editing
2020-01-01 Piazzi, M.; Bavelloni, A.; Gallo, A.; Blalock, W. L.
AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and -2 inhibits deaminase activity
2019-01-01 Bavelloni, A.; Focaccia, E.; Piazzi, M.; Raffini, M.; Cesarini, V.; Tomaselli, S.; Orsini, A.; Ratti, S.; Faenza, I.; Cocco, L.; Gallo, A.; Blalock, W. L.
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity
2021-01-01 Maiani, E.; Milletti, G.; Nazio, F.; Holdgaard, S. G.; Bartkova, J.; Rizza, S.; Cianfanelli, V.; Lorente, M.; Simoneschi, D.; Di Marco, M.; D'Acunzo, P.; Di Leo, L.; Rasmussen, R.; Montagna, C.; Raciti, M.; De Stefanis, C.; Gabicagogeascoa, E.; Rona, G.; Salvador, N.; Pupo, E.; Merchut-Maya, J. M.; Daniel, C. J.; Carinci, M.; Cesarini, V.; O'Sullivan, A.; Jeong, Y. -T.; Bordi, M.; Russo, F.; Campello, S.; Gallo, A.; Filomeni, G.; Lanzetti, L.; Sears, R. C.; Hamerlik, P.; Bartolazzi, A.; Hynds, R. E.; Pearce, D. R.; Swanton, C.; Pagano, M.; Velasco, G.; Papaleo, E.; De Zio, D.; Maya-Mendoza, A.; Locatelli, F.; Bartek, J.; Cecconi, F.
An ADAR that edits transcripts encoding ion channel subunits functions as a dimer
2003-01-01 Gallo, A.; Keegan, L. P.; Ring, G. M.; O'Connell, M. A.
Aptamer-based in vivo therapeutic targeting of glioblastoma
2020-01-01 Cesarini, V.; Scopa, C.; Silvestris, D. A.; Scafidi, A.; Petrera, V.; Del Baldo, G.; Gallo, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Novel Computational Strategy to Identify A-to-I RNA Editing Sites by RNA-Seq Data: De Novo Detection in Human Spinal Cord Tissue | 1-gen-2012 | Picardi, E.; Gallo, A.; Galeano, F.; Tomaselli, S.; Pesole, G. | |
| A-to-I RNA editing and cancer: From pathology to basic science | 1-gen-2008 | Gallo, A.; Galardi, S. | |
| A-to-I RNA editing: The "ADAR" side of human cancer | 1-gen-2012 | Galeano, F.; Tomaselli, S.; Locatelli, F.; Gallo, A. | |
| ADAR enzyme and miRNA story: A nucleotide that can make the difference | 1-gen-2013 | Tomaselli, S.; Bonamassa, B.; Alisi, A.; Nobili, V.; Locatelli, F.; Gallo, A. | |
| ADAR RNA editing in human disease; more to it than meets the I | 1-gen-2017 | Gallo, A.; Vukic, D.; Michalik, D.; O'Connell, M. A.; Keegan, L. P. | |
| ADAR-mediated RNA editing of DNA:RNA hybrids is required for DNA double strand break repair | 1-gen-2021 | Jimeno, S.; Prados-Carvajal, R.; Fernandez-Avila, M. J.; Silva, S.; Silvestris, D. A.; Endara-Coll, M.; Rodriguez-Real, G.; Domingo-Prim, J.; Mejias-Navarro, F.; Romero-Franco, A.; Jimeno-Gonzalez, S.; Barroso, S.; Cesarini, V.; Aguilera, A.; Gallo, A.; Visa, N.; Huertas, P. | |
| ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism | 1-gen-2021 | Tassinari, V.; Cesarini, V.; Tomaselli, S.; Ianniello, Z.; Silvestris, D. A.; Ginistrelli, L. C.; Martini, M.; De Angelis, B.; De Luca, G.; Vitiani, L. R.; Fatica, A.; Locatelli, F.; Gallo, A. | |
| ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas | 1-gen-2013 | Tomaselli, S.; Galeano, F.; Massimi, L.; Di Rocco, C.; Lauriola, L.; Mastronuzzi, A.; Locatelli, F.; Gallo, A. | |
| ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor | 1-gen-2011 | Doria, M.; Tomaselli, S.; Neri, F.; Ciafre, S. A.; Farace, M. G.; Michienzi, A.; Gallo, A. | |
| ADAR2 induces the differentiation of osteosarcoma cells by editing activity on IGFBP7: new implications for therapy | 1-gen-2026 | Rossi, M.; Scotto Di Carlo, F.; Di Gregorio, J.; Russo, S.; Di Giuseppe, L.; Battafarano, G.; Terreri, S.; Pagliarosi, O.; Silvestris, D. A.; Corona, M.; Barra, A.; Pezzullo, M.; De Stefanis, C.; Pelle, S.; Costici, P. F.; Minisola, S.; Pepe, J.; Locatelli, F.; Gianfrancesco, F.; Gallo, A.; Del Fattore, A. | |
| ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature | 1-gen-2022 | Cesarini, V.; Silvestris, D. A.; Galeano, F.; Tassinari, V.; Martini, M.; Locatelli, F.; Gallo, A. | |
| ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis | 1-gen-2013 | Galeano, F.; Rossetti, C.; Tomaselli, S.; Cifaldi, L.; Lezzerini, M.; Pezzullo, M.; Boldrini, R.; Massimi, L.; Di Rocco, C. M.; Locatelli, F.; Gallo, A. | |
| ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion | 1-gen-2018 | Cesarini, V.; Silvestris, D. A.; Tassinari, V.; Tomaselli, S.; Alon, S.; Eisenberg, E.; Locatelli, F.; Gallo, A. | |
| Adars and the balance game between virus infection and innate immune cell response | 1-gen-2015 | Tomaselli, S.; Galeano, F.; Locatelli, F.; Gallo, A. | |
| ADARs: Allies or enemies? The importance of A-to-I RNA editing in human disease: From cancer to HIV-1 | 1-gen-2012 | Gallo, A.; Locatelli, F. | |
| AKT-Dependent Phosphorylation of ADAR1p110 and ADAR2 Represents a New and Important Link between Cell Signaling and RNA Editing | 1-gen-2020 | Piazzi, M.; Bavelloni, A.; Gallo, A.; Blalock, W. L. | |
| AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and -2 inhibits deaminase activity | 1-gen-2019 | Bavelloni, A.; Focaccia, E.; Piazzi, M.; Raffini, M.; Cesarini, V.; Tomaselli, S.; Orsini, A.; Ratti, S.; Faenza, I.; Cocco, L.; Gallo, A.; Blalock, W. L. | |
| AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity | 1-gen-2021 | Maiani, E.; Milletti, G.; Nazio, F.; Holdgaard, S. G.; Bartkova, J.; Rizza, S.; Cianfanelli, V.; Lorente, M.; Simoneschi, D.; Di Marco, M.; D'Acunzo, P.; Di Leo, L.; Rasmussen, R.; Montagna, C.; Raciti, M.; De Stefanis, C.; Gabicagogeascoa, E.; Rona, G.; Salvador, N.; Pupo, E.; Merchut-Maya, J. M.; Daniel, C. J.; Carinci, M.; Cesarini, V.; O'Sullivan, A.; Jeong, Y. -T.; Bordi, M.; Russo, F.; Campello, S.; Gallo, A.; Filomeni, G.; Lanzetti, L.; Sears, R. C.; Hamerlik, P.; Bartolazzi, A.; Hynds, R. E.; Pearce, D. R.; Swanton, C.; Pagano, M.; Velasco, G.; Papaleo, E.; De Zio, D.; Maya-Mendoza, A.; Locatelli, F.; Bartek, J.; Cecconi, F. | |
| An ADAR that edits transcripts encoding ion channel subunits functions as a dimer | 1-gen-2003 | Gallo, A.; Keegan, L. P.; Ring, G. M.; O'Connell, M. A. | |
| Aptamer-based in vivo therapeutic targeting of glioblastoma | 1-gen-2020 | Cesarini, V.; Scopa, C.; Silvestris, D. A.; Scafidi, A.; Petrera, V.; Del Baldo, G.; Gallo, A. |